Maternal outcomes and follow-up of preterm and term neonates born to mothers with systemic lupus erythematosus

References

• Akin MA, Baykan A, Sezer S, Gunes T. Review of literature for the striking clinic picture seen in two infants of mothers with systemic lupus erythematosus. J Matern Fetal Neonatal Med 2011;24:1022–6.
   PubMed Web of Science ®Google Scholar
• Peart E, Clowse ME. Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature. Curr Opin Rheumatol 2014;26:118–23.
   PubMed Web of Science ®Google Scholar
• Sanchez-Manubens J, Ortiz-Santamaria V, Coll Sibina MT, et al. Newborns whose mother has autoimmune disease. A community hospitals’ experience. Reumatol Clin 2013;9:161–5.
   PubMedGoogle Scholar
• Martin V, Lee LA, Askanase AD, et al. Long-term followup of children with neonatal lupus and their unaffected siblings. Arthritis Rheum 2002;46:2377–83.
   PubMed Web of Science ®Google Scholar
• Lawrence JS, Martins CL, Drake GL. A family survey of lupus erythematosus. 1. Heritability. J Rheumatol 1987;14:913–21.
   PubMed Web of Science ®Google Scholar
• Chen CC, Lin KL, Chen CL, et al. Central nervous system manifestations of neonatal lupus: a systematic review. Lupus 2013;22:1484–8.
   PubMed Web of Science ®Google Scholar
• Skog A, Tingstrom J, Salomonsson S, et al. Neurodevelopment in children with and without congenital heart block born to anti-Ro/SSA-positive mothers. Acta Paediatr 2013;102:40–6.
   PubMed Web of Science ®Google Scholar
• Motta M, Rodriguez-Perez C, Tincani A, et al. Neonates born from mothers with autoimmune disorders. Early Hum Dev 2009;85:S67–70.
   PubMed Web of Science ®Google Scholar
• Motta M, Chirico G, Rebaioli CB, et al. Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study. Am J Perinatol 2006;23:247–51.
   PubMed Web of Science ®Google Scholar
• Motta M, Boffa MC, Tincani A, et al. Follow-up of babies born to mothers with antiphospholipid syndrome: preliminary data from the European neonatal registry. Lupus 2012;21:761–3.
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.
   PubMed Web of Science ®Google Scholar
• Ruperto N, Hanrahan LM, Alarcon GS, et al. International consensus for a definition of disease flare in lupus. Lupus 2011;20:453–62.
   PubMed Web of Science ®Google Scholar
• Petri M, Buyon J, Kim M. Classification and definition of major flares in SLE clinical trials. Lupus 1999;8:685–91.
   PubMed Web of Science ®Google Scholar
• Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630–40.
   PubMed Web of Science ®Google Scholar
• Alfirevic Z, Neilson JP. Doppler ultrasonography in high-risk pregnancies: systematic review with meta-analysis. Am J Obstet Gynecol 1995;172:1379–87.
   PubMed Web of Science ®Google Scholar
• Swaak T, Smeenk R. Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA). Ann Rheum Dis 1985;44:245–51.
   PubMed Web of Science ®Google Scholar
• Sperotto F, Cuffaro G, Brachi S, et al. Prevalence of antinuclear antibodies in schoolchildren during puberty and possible relationship with musculoskeletal pain: a longitudinal study. J Rheumatol 2014;41:1405–8.
   PubMed Web of Science ®Google Scholar
• Abeles AM, Abeles M. The clinical utility of a positive antinuclear antibody test result. Am J Med 2013;126:342–8.
   PubMed Web of Science ®Google Scholar
• Fitch-Rogalsky C, Steber W, Mahler M, et al. Clinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodies. PLoS One 2014;9:e93812.
   PubMed Web of Science ®Google Scholar
• Nacinovich R, Galli J, Bomba M, et al. Neuropsychological development of children born to patients with antiphospholipid syndrome. Arthritis Rheum 2008;59:345–51.
   PubMed Web of Science ®Google Scholar
• Ross G, Sammaritano L, Nass R, Lockshin M. Effects of mothers’ autoimmune disease during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adolesc Med 2003;157:397–402.
   PubMedGoogle Scholar
• Smeenk RJ. Antinuclear antibodies: cause of disease or caused by disease? Rheumatology 2000;39:581–4.
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Agmon-Levin N. ‘ASIA’ – autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011;36:4–8.
   PubMed Web of Science ®Google Scholar
• Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991;34:1538–45.
   PubMed Web of Science ®Google Scholar
• Lockshin MD, Reinitz E, Druzin ML, et al. Lupus pregnancy. Case–control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 1984;77:893–8.
   PubMed Web of Science ®Google Scholar
• Petri M, Genovese M, Engle E, Hochberg M. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 1991;34:937–44.
   PubMed Web of Science ®Google Scholar
• Cortes-Hernandez J, Ordi-Ros J, Paredes F, et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 2002;41:643–50.
   PubMed Web of Science ®Google Scholar
• Saavedra MA, Cruz-Reyes C, Vera-Lastra O, et al. Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy. Clin Rheumatol 2012;31:813–9.
   PubMed Web of Science ®Google Scholar
• Yang H, Liu H, Xu D, et al. Pregnancy-related systemic lupus erythematosus: clinical features, outcome and risk factors of disease flares – a case control study. PLoS One 2014;9:e104375
   PubMed Web of Science ®Google Scholar